PRP for Erectile Dysfunction: What the Evidence Actually Says
A clinical review of platelet-rich plasma (PRP) for erectile dysfunction — the evidence base, the limits, and where it fits in a treatment plan.
PRP for Erectile Dysfunction: What the Evidence Actually Says
Dr. Luis Casavantes | Dr. Palmira Morales
Avanti Derma, Tijuana, Mexico
Platelet-rich plasma (PRP) has been marketed aggressively for erectile dysfunction under a range of names, most notably the "P-Shot." Patients researching regenerative options for ED deserve a careful summary of what the evidence supports, what it does not, and where PRP realistically fits in a treatment plan.
What PRP Is
PRP is autologous — it is the patient's own blood, spun down to concentrate platelets and their associated growth factors. When injected into tissue, the growth factors are hypothesized to stimulate cellular repair, angiogenesis (new blood vessel formation), and remodeling of connective tissue.
The mechanism is biologically plausible. The clinical question is how well it works for erectile function specifically, in whom, and by how much.
What the Evidence Supports
Published pilot studies and small trials of intracavernosal PRP for mild-to-moderate ED have reported measurable improvements in International Index of Erectile Function (IIEF-EF) scores at follow-up intervals of 3–6 months. The effect is generally reported as modest, not transformative.
Patients who tend to respond are those with mild-to-moderate ED of a vascular etiology, without severe cavernosal fibrosis, and without severe comorbidities that impair regenerative capacity.
What the Evidence Does Not Support
PRP as a substitute for PDE5 inhibitors in patients for whom PDE5 inhibitors work.
PRP as a definitive treatment for severe ED with established cavernosal fibrosis or venous leak.
Guaranteed outcomes in any patient.
The published literature is heterogeneous, small in sample size, and often lacks long-term follow-up. It is a promising area of investigation, not a settled clinical protocol.
Where PRP Fits
At Avanti Derma we consider PRP for ED in specific clinical contexts:
As an adjunct in mild-to-moderate vascular ED, alongside standard first-line therapy.
In post-surgical recovery to support tissue healing — including alongside PRP and PMMA phalloplasty.
In combination with shockwave and stem cell therapy in appropriately selected patients.
We do not present PRP as a cure for ED. It is one tool in a multimodal approach.
What a Responsible PRP Protocol Looks Like
A responsible PRP protocol involves a diagnostic workup — hormonal panel, vascular assessment, and evaluation of comorbidities — before treatment is recommended. It involves realistic expectation-setting: modest improvement in appropriately selected patients, not transformation.
Clinics that offer PRP as a same-day "P-Shot" with no diagnostic workup, no follow-up plan, and no discussion of first-line alternatives are not practicing evidence-based medicine. They are selling a procedure.
Combination With Other Regenerative Therapies
PRP is often combined with low-intensity extracorporeal shockwave therapy (Li-ESWT), which has its own evidence base for mild-to-moderate vasculogenic ED. The two modalities have complementary mechanisms — shockwave stimulates neovascularization; PRP provides growth factors — and combination protocols are being studied, though again the evidence remains preliminary.
Clinical Takeaways
PRP for ED has biological plausibility and preliminary evidence of modest effect in mild-to-moderate vascular ED.
It is not a substitute for first-line therapy in patients for whom first-line therapy works.
It is not a settled clinical protocol; the evidence base is small and heterogeneous.
A responsible protocol includes diagnostic workup, realistic expectation-setting, and follow-up.
Clinics offering PRP as a same-day fix without workup are selling, not treating.
Bibliography
Epifanova, M.V., et al. "Platelet-Rich Plasma for the Treatment of Erectile Dysfunction: A Systematic Review." Sex Med Rev 8 (2020): 302–311.
Poulios, E., et al. "Platelet-Rich Plasma (PRP) Improves Erectile Function: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial." J Sex Med 18 (2021): 926–935.
Sokolakis, I., Hatzichristodoulou, G. "Clinical Studies on Low-Intensity Extracorporeal Shockwave Therapy for Erectile Dysfunction." Int J Impot Res 31 (2019): 177–194.